Serum Neurofilament-light Chain Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Serum Neurofilament-light Chain Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Publication date: Jun 10, 2019

The investigators hypothesize that serum neurofilament-light chain (NfL) levels can provide information about the level of activity and progression of Multiple Sclerosis at different stages and landmarks of the disease.

Concepts Keywords
Breast Feeding MRI
CIS Medical diagnosis
Cohort Sjögren syndrome
Insurance Amyotrophic lateral sclerosis
MRI Multiple sclerosis
Multiple Sclerosis Neurofilament light polypeptide
Nantes Autoimmune diseases
Neurofilament Biomarkers
Neuromyelitis Optica RTT
NfL Organ systems
Relapse Branches of biology
Serum Medicine
Spectrum MS
Multiple Sclerosis

Semantics

Type Source Name
disease MESH diagnosis
gene UNIPROT NEFL
disease DOID Multiple Sclerosis
disease MESH Multiple Sclerosis
gene UNIPROT TNFSF14
disease MESH relapse
gene UNIPROT CYREN
gene UNIPROT EHD1
disease MESH syndrome
disease DOID syndrome
gene UNIPROT CISH
gene UNIPROT RASL12
disease MESH Neuromyelitis optica spectrum disorder
gene UNIPROT NR4A2
gene UNIPROT ALG3
disease MESH Sclerosis

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *